The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

The analysis covers Cold Agglutinin market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the ...

The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends. Cold Agglutinin Disease Drugs Uptake and Pipeline Development Activities The drugs ...

Recordati is acquiring Sanofi’s Enjaymo, the only approved drug for the rare blood disorder cold agglutinin disease ... A Data-Driven Guide to Patient Access Succes, highlights how focusing ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD ... cleared decrease the need for blood transfusions in patients with CAD, an autoimmune disease which results ...